Physician profile
Thomas E Thielen
NPI 1356440028
$880.85
in general payments reported to CMS, 2019-2025
18 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $38.57 · 2021: $156 · 2022: $142 · 2023: $165 · 2024: $33.38 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $198.33 | 2021-2025 | Azstarys, Azstarys |
| Tris Pharma INC | $141.88 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $120.04 | 2025 | Jornay Pm |
| Pfizer INC. | $67.21 | 2020-2022 | |
| Cranial Technologies, INC | $66.58 | 2019-2024 | Doc Band |
| Neos Therapeutics, Lp | $65.33 | 2019-2023 | Cotempla Xr-Odt |
| Adlon Therapeutics L.P. | $36.05 | 2019-2021 | |
| Abbvie INC. | $20.22 | 2019 | |
| Sobi, INC | $19.61 | 2022 | |
| Sanofi Pasteur INC. | $19.23 | 2023 | |
| Organon LLC | $18.46 | 2025 | |
| Supernus Pharmaceuticals, INC. | $17.83 | 2023 | Qelbree |
| Glaxosmithkline, LLC. | $17.27 | 2022 | |
| Oxford Immunotec USA INC | $16.48 | 2019 | |
| Ironshore Pharmaceuticals INC. | $15.50 | 2023 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $15.45 | 2019 | |
| Shire North American Group INC | $13.34 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Thielen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.